Search

MicroRNAs are small non-coding RNAs that act as rheostats to modulate gene expression during development, physiology, and disease. Approximately half of mammalian microRNAs are intronic. It is unknown whether intronic miRNA transcription depends on their host gene or a microRNA-specific promoter. Here, we show that CRISPR inhibition of host gene Mest downregulated hosted miR-335 in mouse embryonic stem cells and brain organoids. Reciprocally, CRISPR transactivation of Mest upregulated miR-335. By contrast, activation of miR-335 predicted promoter had no effect. Thus, intronic miR-335 expression depends on the promoter activity of its host gene. This approach could serve to map microRNA promoters.

The pituitary gland, the so-called master gland produces and secretes a variety of hormones essential for regulating growth and development, metabolic homeostasis, reproduction, and the stress response. The interplay between the brain and peripheral feedback signals controls hormone secretion from pituitary cells by regulating the properties of ion channels, and in turn, cell excitability. Endocrine anterior pituitary cells fire spontaneous action potentials to regulate their intracellular calcium level and eventually hormone secretion. However, the molecular identity of the non-selective cationic leak channel involved in maintaining the resting membrane potential at the firing threshold remained unknown. Here, we show that the sodium leak channel NALCN, known to modulate neuronal excitability, also regulates excitability in murine anterior pituitary cells. Using viral transduction combined with electrophysiology and calcium imaging we show that NALCN encodes the major Na+ leak conductance which tunes the resting membrane potential close to firing threshold to sustain the intrinsically-regulated firing in endocrine pituitary cells. Genetic interruption of NALCN channel activity, hyperpolarised the membrane potential drastically and stopped the firing activity, and consequently abolished the cytosolic calcium oscillations. Moreover, we found that NALCN conductance forms a very small fraction of the total cell conductance yet has a profound impact on modulating pituitary cell excitability. Taken together, our results demonstrate that, NALCN is a crucial regulator of pituitary cell excitability and supports spontaneous firing activity to consequently regulate hormonal secretion. Our results suggest that receptor-mediated and potentially circadian changes in NALCN conductance can powerfully affect the pituitary activity and hormone secretion.

Cytosolic Ca2+ oscillations provide signaling input to several effector systems of the cell. These include neuronal development, migration and networking. Although similar signaling events are hijacked by highly aggressive cancer cells, the complexity of the ‘neuron-like’ remodeling in metastasis remains to be explored. Here, using a variety of in vitro and in vivo techniques we show that strongly metastatic prostate cancer cells acquire specific Na+/Ca2+ signature required for persistent invasion. We identify the ‘neuronal’ Na+ leak channel, NALCN, at the hot spots of the Ca2+ wave initiation and invadopodia formation. Mechanistically, NALCN associates functionally with plasmalemmal and mitochondrial Na+/Ca2+ exchangers, reactive oxygen species and store-operated channels to generate intracellular Ca2+ oscillations. In turn, this stimulates the activity of protooncogene Src kinase co-localized with NALCN, actin remodeling and secretion of proteolytic enzymes, thus increasing an invasive potential of the cancer cells and metastatic lesions in vivo (accessed in pre-clinical models). Overall, our findings provide new insight into the signaling pathway specific for metastatic cells where NALCN plays the role of the persistent invasion “launcher and controller”.

Freeman-Sheldon syndrome, or distal arthrogryposis type 2A (DA2A), is an autosomal dominant condition caused by mutations in MYH3 and characterized by multiple congenital contractures of the face and limbs and normal cognitive development. We identified a subset of five simplex cases putatively diagnosed with “DA2A with severe neurological abnormalities” in which the proband had Congenital Contractures of the LImbs and FAce, Hypotonia, and global Developmental Delay often resulting in early death, a unique condition that we now refer to as CLIFAHDD syndrome. Exome sequencing identified missense mutations in sodium leak channel, nonselective (NALCN) in four families with CLIFAHDD syndrome. Using molecular inversion probes to screen NALCN in a cohort of 202 DA cases as well as concurrent exome sequencing of six other DA cases revealed NALCN mutations in ten additional families with “atypical” forms of DA. All fourteen mutations were missense variants predicted to alter amino acid residues in or near the S5 and S6 pore-forming segments of NALCN, highlighting the functional importance of these segments. In vitro functional studies demonstrated that mutant NALCN nearly abolished the expression of wildtype NALCN, suggesting that mutations that cause CLIFAHDD syndrome have a dominant negative effect. In contrast, homozygosity for mutations in other regions of NALCN has been reported in three families with an autosomal recessive condition characterized mainly by hypotonia and severe intellectual disability. Accordingly, mutations in NALCN can cause either a recessive or dominant condition with varied though overlapping phenotypic features perhaps depending on the type of mutation and affected protein domain(s).